Companies Cryptocurrencies
Biogen Inc
Biogen Inc
Exchange: Nasdaq Global Select
IPO Date: 17/09/1991
CEO: Mr. Michel Vounatsos
Drug Manufacturers General Healthcare 🔗
  • BIIB
    symbol
  • 264.8
    price
  • 38897262592
    market cap
  • -5.4100037
    changes
If you bought

shares of Biogen Inc (BIIB) on
You would have made
AMOUNT
today.
Old Price $12 Current Price $12

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. The company is headquartered in Cambridge, Massachusetts and currently employs 7,800 full-time employees. The firm focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The firm markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). The company also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin’s lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies. The firm’s product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; CIRARA; BIIB061; BIIB054; BIIB067, and BIIB068.

Address: 225 Binney St Cambridge MASSACHUSETTS 02142

Stay updated.